Neurocircuitry of Emotion: Distinguishing Late Life Anxiety and Depression
Neurocircuitry of Emotion: Distinguishing Late Life Anxiety and Depression
批准号:
8279174
负责人:
Amit Etkin
金额:
$39.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-10 至 2016-04-30
关键词:
AdultAgeAge-associated memory impairmentAging-Related ProcessAmygdaloid structureAnteriorAnxietyAnxiety DisordersBehavioralClinicalCognitiveCognitive deficitsComorbidityConflict (Psychology)ConsciousDataDepressive disorderDevelopmentDifferential DiagnosisDiseaseElderlyEmotionalEmotionsEtiologyExhibitsFinancial compensationFoundationsFunctional Magnetic Resonance ImagingHealthcareImageImpaired cognitionImpairmentIndividual DifferencesInterventionLanguageLateralMeasuresMedialMediatingMemoryMental DepressionMental disordersMood DisordersMorbidity - disease rateNerve DegenerationNeurobiologyNeuropsychological TestsPatientsPatternPerformancePharmacological TreatmentPositioning AttributePrefrontal CortexProcessPublic HealthQuality of lifeRecruitment ActivityRegulationRelapseResourcesRestTimeWorkage relatedage related neurodegenerationbasecognitive controlcognitive functiondisabilityemotion regulationexecutive functionfallsgeriatric depressioninnovationmortalityneural circuitneuroimagingneuropsychologicalnovelolder patientparallel processingrelating to nervous systemresiliencetherapeutic targettreatment responseyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application aims to delineate the neural basis of late life anxiety and depressive disorders. As many as 15% of adults over the age of 60 years in the U.S. suffer from anxiety or depressive disorders. These disorders in late life are disabling, reduce the quality of life, impair cognitive processing and increase morbidity and mortality. Little is known about the neurocircuitry underlying these disorders in older adults, an issue that is further complicated by the neurodegenerative changes that accompany the aging process. Increased characterization of the neural basis of late life mood and anxiety disorders is essential for increasing our understanding of a) the etiology of these disorders; b) their differential diagnosis; c) their relationship to age- related neurodegeneration and cognitive decline; d) vulnerability and resilience factors; e) predictors of treatment response; and also for the f) establishment of the basis for development of rational therapeutics targeting defined neural circuits. We propose to provide this much-needed neurobiological foundation by investigating in patients with late life depression and anxiety innovative fMRI paradigms that we have utilized to identify differential neural substrates of depression and anxiety in young adults that both characterize and distinguish these disorders. To achieve our objective of characterizing late life MDD and GAD at a neural circuit level, we will apply these neuroimaging probes to 160 older adults (>60 years old) falling equally into four groups: GAD only, MDD only, comorbid GAD/MDD and healthy controls, while also examining non- emotional cognitive control processes that parallel emotion regulatory ones, and assessing a range of cognitive functions through neuropsychological testing. Our Specific Aims, based on our preliminary data and considerations regarding age-related cognitive decline, are: Aim 1: To examine if fMRI measures of emotional processing and regulation are associated with different patterns of impaired neurocircuitry in late life GAD versus late life MDD. Aim 2: To examine if neurocircuitry abnormalities in co-morbid late life GAD and MDD are additive. Aim 3: To examine if dysregulation of emotional processing in late life GAD and MDD is due to impaired executive control during cognitive processing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validating of Machine Learning-Based EEG Treatment Biomarkers in Depression
-
批准号:10009501
-
项目类别:
-
资助金额:$98.81万
-
财政年份:2020
-
负责人:Amit Etkin
-
依托单位:
Validating of Machine Learning-Based EEG Treatment Biomarkers in Depression
-
批准号:10116492
-
项目类别:
-
资助金额:$118.41万
-
财政年份:2020
-
负责人:Amit Etkin
-
依托单位:
Validating of Machine Learning-Based EEG Treatment Biomarkers in Depression
-
批准号:10366060
-
项目类别:
-
资助金额:$101.65万
-
财政年份:2020
-
负责人:Amit Etkin
-
依托单位:
Assessing an electroencephalography (EEG) biomarker of response to transcranial magnetic stimulation for major depression
-
批准号:9933192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Amit Etkin
-
依托单位:
A "Circuits-First" Platform for Personalized Neurostimulation Treatment
-
批准号:10214488
-
项目类别:
-
资助金额:$101.5万
-
财政年份:2019
-
负责人:Amit Etkin
-
依托单位:
A "Circuits-First" Platform for Personalized Neurostimulation Treatment
-
批准号:10000142
-
项目类别:
-
资助金额:$93.1万
-
财政年份:2019
-
负责人:Amit Etkin
-
依托单位:
A "Circuits-First" Platform for Personalized Neurostimulation Treatment
-
批准号:10019435
-
项目类别:
-
资助金额:$109.9万
-
财政年份:2019
-
负责人:Amit Etkin
-
依托单位:
A Circuit Approach to Mechanisms and Predictors of Topiramate Response
-
批准号:10473684
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2018
-
负责人:Amit Etkin
-
依托单位:
A Circuit Approach to Mechanisms and Predictors of Topiramate Response
-
批准号:10237286
-
项目类别:
-
资助金额:$43.96万
-
财政年份:2018
-
负责人:Amit Etkin
-
依托单位:
A “Circuits-First” Platform for Personalized Neurostimulation Treatment
-
批准号:9552929
-
项目类别:
-
资助金额:$109.9万
-
财政年份:2017
-
负责人:Amit Etkin
-
依托单位:
A “Circuits-First” Platform for Personalized Neurostimulation Treatment
-
批准号:9339858
-
项目类别:
-
资助金额:$109.9万
-
财政年份:2017
-
负责人:Amit Etkin
-
依托单位:
Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions
-
批准号:9146318
-
项目类别:
-
资助金额:$62.34万
-
财政年份:2015
-
负责人:Amit Etkin
-
依托单位:
Mapping and Manipulating Circuits for Emotion and Cognition in Anxiety and Depression
-
批准号:9315908
-
项目类别:
-
资助金额:$60.91万
-
财政年份:2014
-
负责人:Amit Etkin
-
依托单位:
Developing Methods for Brain Stimulation Enhanced Fear Reversal in PTSD
-
批准号:8897452
-
项目类别:
-
资助金额:$7.05万
-
财政年份:2014
-
负责人:Amit Etkin
-
依托单位:
Mapping and Manipulating Circuits for Emotion and Cognition in Anxiety and Depression
-
批准号:9109051
-
项目类别:
-
资助金额:$77.4万
-
财政年份:2014
-
负责人:Amit Etkin
-
依托单位:
Mapping and Manipulating Circuits for Emotion and Cognition in Anxiety and Depression
-
批准号:8817396
-
项目类别:
-
资助金额:$84.59万
-
财政年份:2014
-
负责人:Amit Etkin
-
依托单位:
Emotion Regulation in Anxiety & Depression: A Novel Neurobehavioral Intervention
-
批准号:8911365
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2012
-
负责人:Amit Etkin
-
依托单位:
Emotion Regulation in Anxiety & Depression: A Novel Neurobehavioral Intervention
-
批准号:8516596
-
项目类别:
-
资助金额:$21.07万
-
财政年份:2012
-
负责人:Amit Etkin
-
依托单位:
Emotion Regulation in Anxiety & Depression: A Novel Neurobehavioral Intervention
-
批准号:8364836
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2012
-
负责人:Amit Etkin
-
依托单位:
Emotion Regulation in Anxiety & Depression: A Novel Neurobehavioral Intervention
-
批准号:8744326
-
项目类别:
-
资助金额:$23.98万
-
财政年份:2012
-
负责人:Amit Etkin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: